MCKENZIE MOOR: Open Payments
NPI 1205230950 · WILLISTON, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 13 payments from 7 companies in 2025. Trend: 2023 $154 · 2024 $240 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Alkermes, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: TRINTELLIX, Auvelity, ARISTADA, AUSTEDO XR, HETLIOZ, REXULTI, INGREZZA.
Industry payments across ND — which companies pay providers there.
